221 related articles for article (PubMed ID: 28795285)
1. Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean.
Dookeeram D; Bidaisee S; Paul JF; Nunes P; Robertson P; Maharaj VR; Sammy I
Int J Clin Pharm; 2017 Oct; 39(5):1119-1127. PubMed ID: 28795285
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
3. Association of inappropriate polypharmacy with emergency department visits in older patients receiving anti-neoplastic therapy: a population-based study.
Suh Y; Ah YM; Lee E; Lee JY
Support Care Cancer; 2021 Jun; 29(6):3025-3034. PubMed ID: 33037903
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department.
Hohl CM; Dankoff J; Colacone A; Afilalo M
Ann Emerg Med; 2001 Dec; 38(6):666-71. PubMed ID: 11719747
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and drug-drug interactions among older and younger male prisoners in Switzerland.
Annaheim B; Wangmo T; Bretschneider W; Handtke V; Elger BS; Belardi A; Meyer AH; Hösli R; Lutters M
Int J Prison Health; 2019 Aug; 15(3):250-261. PubMed ID: 31329038
[TBL] [Abstract][Full Text] [Related]
9. Is polypharmacy an independent risk factor for adverse outcomes after an emergency department visit?
Salvi F; Rossi L; Lattanzio F; Cherubini A
Intern Emerg Med; 2017 Mar; 12(2):213-220. PubMed ID: 27075646
[TBL] [Abstract][Full Text] [Related]
10. Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study.
Marino A; Capogrosso-Sansone A; Tuccori M; Bini G; Calsolaro V; Mantarro S; Convertino I; Pasqualetti G; Orsitto E; Santini M; Monzani F; Blandizzi C;
Expert Opin Drug Saf; 2016 Dec; 15(sup2):45-50. PubMed ID: 27875918
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors.
Oliveira RF; Oliveira AI; Cruz AS; Ribeiro O; Afreixo V; Pimentel F
BMC Geriatr; 2024 Jun; 24(1):557. PubMed ID: 38918696
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interactions in a cohort of hospitalized elderly patients.
Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with adverse drug events among older adults in emergency department.
Chen YC; Fan JS; Chen MH; Hsu TF; Huang HH; Cheng KW; Yen DH; Huang CI; Chen LK; Yang CC
Eur J Intern Med; 2014 Jan; 25(1):49-55. PubMed ID: 24200546
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interactions associated with length of stay and cost of hospitalization.
Moura CS; Acurcio FA; Belo NO
J Pharm Pharm Sci; 2009; 12(3):266-72. PubMed ID: 20067703
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
[TBL] [Abstract][Full Text] [Related]
16. [Drug-drug interactions in multicentre polypathological polymedicated patients].
Galindo-Ocaña J; Gil-Navarro MV; García-Morillo JS; Bernabeu-Wittel M; Ollero-Baturone M; Ortiz-Camuñez MA
Rev Clin Esp; 2010 Jun; 210(6):270-8. PubMed ID: 20434722
[TBL] [Abstract][Full Text] [Related]
17. The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults.
Novaes PH; da Cruz DT; Lucchetti ALG; Leite ICG; Lucchetti G
Int J Clin Pharm; 2017 Aug; 39(4):818-825. PubMed ID: 28455830
[TBL] [Abstract][Full Text] [Related]
18. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine.
Schrecker J; Puet B; Hild C; Schwope DM
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):973-978. PubMed ID: 30092669
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population.
Goldberg RM; Mabee J; Chan L; Wong S
Am J Emerg Med; 1996 Sep; 14(5):447-50. PubMed ID: 8765105
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
Sheikh-Taha M; Asmar M
BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
